North America Coronary and Peripheral Stents Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Coronary and Peripheral Stents Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Coronary and Peripheral Stents Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Coronary and Peripheral Stents Market Regional Analysis

6.2 North America Coronary and Peripheral Stents Market Revenue 2022-2033 (US$ Million)

6.3 North America Coronary and Peripheral Stents Market Forecast Analysis

7. North America Coronary and Peripheral Stents Market Analysis – by Product Type

7.1 Bare-Metal Stents

7.1.1 Overview
7.1.2 Bare-Metal Stents: North America Coronary and Peripheral Stents Market – Revenue and Forecast, 2022-2033 (US$ Million)

7.2 Drug-Eluting Stents

7.2.1 Overview
7.2.2 Drug-Eluting Stents: North America Coronary and Peripheral Stents Market – Revenue and Forecast, 2022-2033 (US$ Million)

7.3 Bioresorbable Vascular Scaffolds

7.3.1 Overview
7.3.2 Bioresorbable Vascular Scaffolds: North America Coronary and Peripheral Stents Market – Revenue and Forecast, 2022-2033 (US$ Million)

7.4 Others

7.4.1 Overview
7.4.2 Others: North America Coronary and Peripheral Stents Market – Revenue and Forecast, 2022-2033 (US$ Million)

8. North America Coronary and Peripheral Stents Market Analysis – by Material Type

8.1 Metal

8.1.1 Overview
8.1.2 Metal: North America Coronary and Peripheral Stents Market – Revenue and Forecast, 2022-2033 (US$ Million)

8.2 Polymer

8.2.1 Overview
8.2.2 Polymer: North America Coronary and Peripheral Stents Market – Revenue and Forecast, 2022-2033 (US$ Million)

8.3 Hybrid

8.3.1 Overview
8.3.2 Hybrid: North America Coronary and Peripheral Stents Market – Revenue and Forecast, 2022-2033 (US$ Million)

9. North America Coronary and Peripheral Stents Market Analysis – by Application

9.1 Coronary Artery Disease

9.1.1 Overview
9.1.2 Coronary Artery Disease: North America Coronary and Peripheral Stents Market – Revenue and Forecast, 2022-2033 (US$ Million)

9.2 Peripheral Artery Disease

9.2.1 Overview
9.2.2 Peripheral Artery Disease: North America Coronary and Peripheral Stents Market – Revenue and Forecast, 2022-2033 (US$ Million)

10. North America Coronary and Peripheral Stents Market Analysis – by End User

10.1 Hospitals

10.1.1 Overview
10.1.2 Hospitals: North America Coronary and Peripheral Stents Market – Revenue and Forecast, 2022-2033 (US$ Million)

10.2 Ambulatory Surgical Centers

10.2.1 Overview
10.2.2 Ambulatory Surgical Centers: North America Coronary and Peripheral Stents Market – Revenue and Forecast, 2022-2033 (US$ Million)

10.3 Cardiac Catheterization Labs

10.3.1 Overview
10.3.2 Cardiac Catheterization Labs: North America Coronary and Peripheral Stents Market – Revenue and Forecast, 2022-2033 (US$ Million)

10.4 Specialty Clinics

10.4.1 Overview
10.4.2 Specialty Clinics: North America Coronary and Peripheral Stents Market – Revenue and Forecast, 2022-2033 (US$ Million)

11. North America Coronary and Peripheral Stents Market – North America Analysis

11.1 Overview

11.2 North America

11.2.1 North America Coronary and Peripheral Stents Market Breakdown, by Key Country, 2025 and 2033 (%)
11.2.1.1 North America Coronary and Peripheral Stents Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: North America Coronary and Peripheral Stents Market – Revenue and Forecast to 2033 (US$ Million)

11.2.1.1.1 US: North America Coronary and Peripheral Stents Market Breakdown, by Product Type
11.2.1.1.2 US: North America Coronary and Peripheral Stents Market Breakdown, by Material Type
11.2.1.1.3 US: North America Coronary and Peripheral Stents Market Breakdown, by Application
11.2.1.1.4 US: North America Coronary and Peripheral Stents Market Breakdown, by End User

11.2.1.2 Canada: North America Coronary and Peripheral Stents Market – Revenue and Forecast to 2033 (US$ Million)

11.2.1.2.1 Canada: North America Coronary and Peripheral Stents Market Breakdown, by Product Type
11.2.1.2.2 Canada: North America Coronary and Peripheral Stents Market Breakdown, by Material Type
11.2.1.2.3 Canada: North America Coronary and Peripheral Stents Market Breakdown, by Application
11.2.1.2.4 Canada: North America Coronary and Peripheral Stents Market Breakdown, by End User

11.2.1.3 Mexico: North America Coronary and Peripheral Stents Market – Revenue and Forecast to 2033 (US$ Million)

11.2.1.3.1 Mexico: North America Coronary and Peripheral Stents Market Breakdown, by Product Type
11.2.1.3.2 Mexico: North America Coronary and Peripheral Stents Market Breakdown, by Material Type
11.2.1.3.3 Mexico: North America Coronary and Peripheral Stents Market Breakdown, by Application
11.2.1.3.4 Mexico: North America Coronary and Peripheral Stents Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Medtronic

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Boston Scientific Corporation

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Abbott

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 B. Braun SE

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 TERUMO CORPORATION

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Teleflex Incorporated

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Lepu Medical Technology (Beijing) Co. Ltd.

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Cook Medical

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Meril Life Sciences

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Translumina

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

North America Coronary and Peripheral Stents Market Outlook (2022-2033)